Nagase increases rare amino acid productivity using Smart Cell technology

The Nagase R&D Center, the research and development arm of NAGASE & CO., LTD. based in Tokyo, has been deve...

October 8, 2020 | Thursday | News
Eisai to involve jointly in COVID-19 drug discovery utilizing Eritoran and E6011

Japan's Eisai has entered into a joint research agreement with four research organizations (KAN Research Institute, Nati...

October 7, 2020 | Wednesday | News
Japan invents novel tool to alter gene activity in stem cells

Researchers from Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and Tokai University i...

October 6, 2020 | Tuesday | News
Shionogi partners with HanaVax for pneumonia vaccine candidate

Shionogi & Co. and HanaVax Inc., both based in Japan, have announced they have entered into a license agreement for ...

October 5, 2020 | Monday | News
Shionogi examines mortality in patients with severe bacterial infections

Shionogi & Co. Ltd., a global, research-driven pharmaceutical company headquartered in Osaka, Japan (Shionogi) has r...

October 1, 2020 | Thursday | News
OriCiro launches world's first cell-free circular DNA amplification technology

Japanese firm OriCiro Genomics, a pioneer in the cell-free synthesis and amplification of genome-scale large DNA for gen...

October 2, 2020 | Friday | News
Aji Bio-Pharma, DNDi to develop treatment for cutaneous leishmaniasis infections

Japan's Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development a...

October 1, 2020 | Thursday | News
Japan gathers genetic information for predicting COVID-19 severity

Japanese researchers have launched the Joint Research Coronavirus Task Force to gather genetic information for predictin...

September 30, 2020 | Wednesday | News
GHIT Fund infuses 1.37 B yen to develop new lifesaving drugs

The Global Health Innovative Technology (GHIT) Fund in Japan has announced a total of 1.37 billion yen to invest in...

September 29, 2020 | Tuesday | News
Japan approves Jyseleca for rheumatoid arthritis treatment

Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that the Japanese Ministry of Health, Labour and Welfare (MHLW)...

September 28, 2020 | Monday | News
Sun Pharma launches plaque psoriasis drug in Japan

Indian firm Sun Pharmaceutical Industries has announced that its wholly-owned Japanese subsidiary has launched ILUM...

September 24, 2020 | Thursday | News
Avigan shows promising results in treating COVID-19 patients in Japan

Healthcare solutions provider Global Response Aid (GRA) and Dr. Reddy's Laboratories announced that the anti-viral ...

September 24, 2020 | Thursday | News
Hitachi Chemical adopts new name for global regenerative medicine biz

The regenerative medicine business of Hitachi Chemical, headquartered in Japan, has announced that it has adopted the na...

September 24, 2020 | Thursday | News
Takeda inks evaluation agreement with Elektrofi

Elektrofi, a US based biotechnology company focused on drug formulation and delivery innovations, has announced it has e...

September 23, 2020 | Wednesday | News
Eisai receives EMA's CHMP approval for Antiepileptic agent Fycompa for pediatric use

Eisai Co., Ltd. on 23 announced that it has received a positive opinion from the European Medicines Agency (EMA)'s Commi...

September 23, 2020 | Wednesday | News
Takeda to divest TachoSil for €350 M

Takeda Pharmaceutical Company has announced that it has entered into an agreement to divest its TachoSil® Fibri...

September 18, 2020 | Friday | News
VR startup in US brings immersive drug design software to Japan

US based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature p...

September 17, 2020 | Thursday | News
Takeda opens new R&D cell therapy manufacturing facility

Takeda Pharmaceutical Company Limited in Japan has announced the expansion of its cell therapy manufacturing c...

September 16, 2020 | Wednesday | News